This project explores the innovative application of molecular hydrogen technology (MHT) in a saline-rich intravenous formulation. As research continues to unveil the therapeutic potential of molecular hydrogen, our focus is on its administration through a saline medium, which may enhance its bioavailability and efficacy in clinical settings.